Advertisement
Screener

Foamix Pharmaceuticals Ltd. Form PRER14A: Revised preliminary proxy statement

Foamix Pharmaceuticals Ltd. Form PRER14A: Revised preliminary proxy statement

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2019-03-08: Form PRER14A; Description PRE 14A; Document zk1922787.htm.
FiledFormPeriod of reportDescriptionDocument
2019-03-08PRER14APRE 14Azk1922787.htm